In person Molecular glues and targeted protein degraders are changing the landscape of drug discovery. They show great potential for treating diseases such as cancer, infectious, inflammatory, andneurodegenerative diseases, especially for those with “undruggable” pathogenic protein targets. With therecent rise of the ‘molecular glue’ type of protein degraders, new therapies for unmet medical needs are…
16th Winter Conference on Medicinal & Bioorganic Chemistry
In person ZoBio was attending 16th Winter Conference on Medicinal & Bioorganic Chemistry held in the beautiful Steamboat Springs Resort, Colorado. The conference exposed attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery.In addition to the scientific presentations, this meeting provided a…
SMR Meeting: Recent Trends in Medicinal Chemistry and Enabling Technologies
In person On 8th December 2022, the Society for Medicines Research and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry were jointly hosting a 1-day meeting in London on Recent Trends in Medicinal Chemistry and Enabling Technologies. The meeting was a combination of medicinal chemistry, chemistry-based drug discovery enabling technologies and…
Cytiva™ Analytical Workshop 2022
Hybrid On November 29th Masakazu Kobayashi (Head of Assay Development and Screening Group) participated in a Cytiva™ Analytical Workshop in Tokyo, Japan. He presented a case study entitled: ‘Use of multiple biophysical assays to interrogate hit tractability in early drug discovery‘. The Cytiva™ Analytical Workshop (CAWS) originally started in 2014 with the theme of the…